posteditor

B SHENZHEN, China, April 20, 2026 /PRNewswire/ — This year marks the 5th anniversary of the Global Development Initiative (GDI). “Telling China’s Story: The Friendship… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B The National Comprehensive Cancer Network recognizes people whose leadership, commitment, and dedication helped NCCN break new ground to define and advance quality, effective, equitable,… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

““Working with Sir Ben Kingsley again is a huge honour. Our earlier collaboration showed the extraordinary power of film to engage global audiences with stories… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

A Sheinelle Jones turned 48 on Sunday, April 19, marking her first birthday celebration since the death of her husband, Uche Ojeh, in May 2025.… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B BEIJING, April 20, 2026 /PRNewswire/ — VNET Group, Inc. (Nasdaq: VNET) (“VNET” or the “Company”), today announced that Mr. Qiyu Wang has resigned from his… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B NEW YORK, April 20, 2026 /PRNewswire/ — MobileFuse, a leading advertising and technology platform, today announced it has earned Trustworthy Accountability Group (TAG) Platinum Recertification… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B Technology will enhance country’s electronic warfare capabilities ARLINGTON, Va., April 20, 2026 /PRNewswire/ — Raytheon, an RTX (NYSE: RTX) business, has delivered its first… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B The new Artlist Studio offers shot-by-shot directorial control, bringing production-grade generative tools to professional creators TEL AVIV, Israel, April 20, 2026 /PRNewswire/ — Artlist,… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B New data demonstrate the IL-22 AND-Body™ therapeutic, AMP-220, selectively targets gut tissue, conferring improved therapeutic efficacy and tolerability in vivo IND-enabling studies for AMP-220… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B Order value of approximately USD 68M with mass production to begin in 2027 Offering data transmission speed three times faster, with no speed degradation… Login to continue reading Login Sign up for complimentary access Sign Up Now Close